Recall archive / FDA device enforcement
Total Resources International First Aid Kits, Item Numbers: 10HBC01087, 10HBC01092A3PK, 10HBC01112, 10HBC01113, 10HBC... — FDA record Z-1089-2022
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Mar 11, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Total Resources International First Aid Kits, Item Numbers: 10HBC01087, 10HBC01092A3PK, 10HBC01112, 10HBC01113, 10HBC01329GLRV1, 10OUT02086GLRV2, 16BLU01495, 20HBC01015CCREV3, 20HBC01084GLOWCC. Kit contents include ULTRAtab Laboratories Coated APAP 325 mg (Acetaminophen 325 mg), Product Code: L202L.
- Reason
- ULTRAtab Laboratories recalled Acetaminophen and electrolyte tablets that were later placed into Total Resources Intl kits. Acetaminophen and electrolyte tablets were recalled due to a Fluid Bed Drier exhaust system breach, which presents the possibility of cross-contamination where the potential contaminations are well known API's at well below efficacious dose levels.
- Classification
- Class II
- Recalling firm
- Total Resources Intl
- Quantity
- 188915
- Agency-reported status
- Terminated
- Source record identifier
- Z-1089-2022
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Kit Item No./Lot/Expiration/Best if Used by Date: 10HBC01087/20097-03/6/30/2022; 10HBC01092A3PK/20086-10/6/30/2022; 10HBC01112/20100-10/6/30/2022; 10HBC01113/20062-04, 20063-04, 20064-04, 20083-04, 20084-03, 20085-03, 20104-03, 20105-03, 20106-03/6/30/2022; 10HBC01329GLRV1/20072-05, 20073-05, 20079-05, 20080-05, 20083-05, 20085-05, 20086-05/6/30/2022; 10OUT02086GLRV2/20086-04, 20087-04, 20090-04, 20091-04, 20092-04, 20093-04, 20094-04, 20097-04, 20098-04, 20099-04/6/30/2022; 16BLU01495/ 20079-10/6/30/2022; 20HBC01015CCREV3/20071-10/6/30/2022; 20HBC01084GLOWCC/20090-05, 20091-05, 20092-05, 20093-05/1/31/2022; 20HBC01084GLOWCC/20083-10, 20094-05, 20098-05/5/31/2022; 20HBC01084GLOWCC/20076-01, 20077-01, 20087-05/06/30/2022 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
US: IL, PA, VA, AR, TX, IA, DE, GA, NY, LA, AL, IN, MI, MO, NC, KS, CO, AZ, OH, MS, CA, FL, WI, KY, UT, OR, NH, TN, NV, CT
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- May 25, 2022
- Recall initiation date
- Mar 11, 2022
- Center classification date
- May 13, 2022
- Termination date
- Jan 30, 2025
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.